Tuesday 21 October 2014

Giving pricey hepatitis drug to prisoners may be financially wise

By Andrew M. Seaman NEW YORK (Reuters Health) - When prisoners have hepatitis C, treating them with expensive new antiviral drugs makes fiscal sense despite the hefty price tag, according to a new study. Based on computer models, new pricey drug combinations that treat hepatitis C infections were more cost-effective than older drug combinations and no treatment at all, researchers found. “Essentially what our model does is follow a hypothetical cohort of prisoners that looks like a prison population in the U.S.,” Jeremy Goldhaber-Fiebert told Reuters Health. ... via Health News Headlines - Yahoo News Read More Here..

No comments:

Post a Comment